Ipca Laboratories Ltd. - Research Center
524494 IPCALAB Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Mar ' 20 | Sep ' 19 | Sep ' 18 | Sep ' 17 | Sep ' 16 | |
|---|---|---|---|---|---|
| Sales | 2,143.86 | 2,223.57 | 1,851.75 | 1,577.25 | 1,714.19 |
| Operating profit | 458.16 | 456.60 | 286.80 | 170.55 | 256.54 |
| Interest | 7.27 | 8.52 | 7.31 | 11.97 | 13.61 |
| Gross profit | 481.82 | 481.84 | 306.87 | 175.76 | 253.99 |
| EPS (Rs) | 25.67 | 25.97 | 14.66 | 6.04 | 8.12 |
Half yearly
results in details
| Mar ' 20 | Sep ' 19 | Sep ' 18 | Sep ' 17 | Sep ' 16 | |
|---|---|---|---|---|---|
| Other income | 30.93 | 33.76 | 27.38 | 17.18 | 11.06 |
| Stock adjustment | -118.05 | -37.00 | -29.66 | 18.54 | 64.70 |
| Raw material | 721.69 | 709.41 | 537.70 | 472.33 | 488.60 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 445.60 | 425.19 | 399.17 | 361.87 | 335.09 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 636.46 | 669.37 | 657.74 | 553.96 | 569.26 |
| Provisions made | - | - | - | - | - |
| Depreciation | 91.54 | 87.15 | 87.65 | 87.39 | 85.07 |
| Taxation | 65.89 | 66.62 | 33.96 | 12.15 | 66.40 |
| Net profit / loss | 324.39 | 328.07 | 185.26 | 76.22 | 102.52 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 25.27 | 25.27 | 25.27 | 25.24 | 25.24 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 21.37 | 20.53 | 15.49 | 10.81 | 14.97 |
| GPM (%) | 22.15 | 21.35 | 16.33 | 11.02 | 14.72 |
| NPM (%) | 14.92 | 14.53 | 9.86 | 4.78 | 5.94 |
Mutual Fund Selector
Find the fund that is right for you
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis